Previous 10 | Next 10 |
IRVINE, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (Nasdaq: MRIC) (the “Company”), a leading platform neurosurgery company, today announced preliminary and unaudited results for the quarter ended December 31, 2019. Additionally, the Company announced a $...
IRVINE, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (Nasdaq: MRIC) (the “Company”), a leading platform neurosurgery company, today announced plans to change its corporate name to ClearPoint Neuro, Inc. As part of the name change, the Company will release ...
The following slide deck was published by MRI Interventions, Inc. in conjunction with this Read more ...
IRVINE, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) (the “ Company ”) today announced that it will voluntarily move its stock exchange listing from the NYSE American LLC to the Nasdaq Capital Market. The Company expects its common st...
Thinly traded nano cap MRI Interventions (NYSEMKT: MRIC ) is up 22% premarket, albeit on only 200 shares, on the heels of its Q3 report released after the close yesterday. Highlights: More news on: MRI Interventions, Inc., Healthcare stocks news, Earnings news and commentary,...
MRI Interventions, Inc. (MRIC) Q3 2019 Earnings Conference Call November 12, 2019 4:30 PM ET Company Participants Joe Burnett - Chief Executive Officer and Director Hal Hurwitz - Chief Financial Officer and Corporate Secretary Conference Call Participants Presentation O...
MRI Interventions (NYSEMKT: MRIC ): Q3 GAAP EPS of -$0.08. More news on: MRI Interventions, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
IRVINE, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) (the “Company”) today announced financial results for its third fiscal quarter ended September 30, 2019. 2019 Third Quarter Highlights Increased revenue 62% year-over-yea...
IRVINE, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC), a platform neurosurgery company with products designed to deliver navigation, ablation, deep brain stimulation, biopsy and gene therapy, today announced that it will release financial results fo...
IRVINE, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) today announced that Chief Executive Officer Joe Burnett will present at the at the Sidoti Fall Investor Conference on Wednesday, September 25, 2019. The event will be held at the Grand Hya...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results for its 2020 first quarter, which ended March 31, 2020, on Tuesday, May 12, 2020 after the market close. The Company wi...
IRVINE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results for its 2020 first quarter, which ended March 31, 2020, on Tuesday, May 12, 2020 after the market close. Investors a...
IRVINE, Calif., April 17, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) is pleased to announce that Matthew B. Klein, MD, MS, FACS, has been appointed to ClearPoint Neuro’s Board of Directors effective immediately. Dr. Klein, Chief Development Officer of PTC Therapeu...